Adaptive Biotechnologies Corporation
Status: Publicly traded
Direct answer
Adaptive Biotechnologies Corporation is publicly traded on NASDAQ under the ticker ADPT.
Adaptive Biotechnologies Corporation, founded in 2009 and headquartered in Seattle, Washington (operating as Adaptive TCR Corporation until its name change in December 2011), is a commercial-stage entity focused on pioneering an immune medicine platform. This advanced platform is engineered for the precise diagnosis and effective treatment of a broad spectrum of illnesses. The company offers several core...
Can you invest in Adaptive Biotechnologies Corporation?
Yes. Adaptive Biotechnologies Corporation trades publicly on NASDAQ as ADPT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Adaptive Biotechnologies Corporation
Detailed equity research is provided by MarketSnap.